Cholesterol derivatives based charged liposomes for doxorubicin delivery: preparation, in vitro and in vivo characterization
about
Nanotheranostics - application and further development of nanomedicine strategies for advanced theranosticsLiposomes as nanomedical devicesPoly(ethylene glycol)-cholesterol inhibits L-type Ca2+ channel currents and augments voltage-dependent inactivation in A7r5 cellsCurrent progress in gene delivery technology based on chemical methods and nano-carriersImage-guided drug delivery to the brain using nanotechnology.Nanolipolee-007, a novel nanoparticle-based drug containing leelamine for the treatment of melanoma.Effect of PEG pairing on the efficiency of cancer-targeting liposomesMono-arginine Cholesterol-based Small Lipid Nanoparticles as a Systemic siRNA Delivery Platform for Effective Cancer Therapy.Cancer Theranostic Nanoparticles Self-Assembled from Amphiphilic Small Molecules with Equilibrium Shift-Induced Renal Clearance.Injectable liposomal formulations of opiorphin as a new therapeutic strategy in pain management.Effects of Liposomes Charge on Extending Sciatic Nerve Blockade of N-ethyl Bromide of Lidocaine in Rats.A novel strategy inducing autophagic cell death in Burkitt's lymphoma cells with anti-CD19-targeted liposomal rapamycin.Liposomal chemotherapeutics.Targeting delivery of liposomes with conjugated p-aminophenyl-α-d-manno-pyranoside and apolipoprotein E for inhibiting neuronal degeneration insulted with β-amyloid peptide.Physical properties and biological interactions of liposomes developed as a drug carrier in the field of regenerative medicine.Preparation and evaluation of charged solid lipid nanoparticles of tetrandrine for ocular drug delivery system: pharmacokinetics, cytotoxicity and cellular uptake studies.Enhanced blood-brain barrier transmigration using a novel transferrin embedded fluorescent magneto-liposome nanoformulation.Biochemical characterization of the interactions between doxorubicin and lipidic GM1 micelles with or without paclitaxel loading.Preparation and optimisation of anionic liposomes for delivery of small peptides and cDNA to human corneal epithelial cells.Synthesis, antimicrobial and cytotoxicity evaluation of new cholesterol congenersImage guided biodistribution of drugs and drug delivery.A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery.Development and evaluation of exemestane-loaded lyotropic liquid crystalline gel formulations.Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.cRGD-conjugated magnetic-fluorescent liposomes for targeted dual-modality imaging of bone metastasis from prostate cancer.Combination of doxorubicin with harmine-loaded liposomes exerting synergistic antitumor efficacy.Noninvasive visualization of early osteoarthritic cartilage using targeted nanosomes in a destabilization of the medial meniscus mouse model.Effective Delivery of Arsenic Trioxide to HPV-Positive Cervical Cancer Cells Using Optimised Liposomes: A Size and Charge Study.Enhancement of oral bioavailability of doxorubicin through surface modified biodegradable polymeric nanoparticles.Liposomal formulations of carboplatin injected by convection-enhanced delivery increases the median survival time of F98 glioma bearing rats
P2860
Q26860760-5E23F00F-A26A-49B5-A9A2-BBC03737CEF2Q28088315-EB06AC03-9485-4C54-8849-5B677F07F10BQ28542865-855B3CF5-7E0E-4B72-8525-59B0B6466AF9Q28659480-675F93D7-F426-4B04-AC9E-69210B252E39Q30426990-97E61C76-E537-4DD4-92F6-10FDFFE7451CQ35225907-181934E3-CB58-4BC1-8BC8-1C5D7585CD65Q35475998-CB381ED0-71F1-42DC-A1E9-BA960FE7EF45Q36510849-FAA86E78-EE4E-4779-AEDA-BD288811957AQ37112982-3DE1860F-44D2-4DD8-ACA9-4DADA36A5C2BQ37474355-14A2BEFB-DB6E-43AD-AE2D-5EB214A4058AQ37479784-CCEEF7AE-0BBE-40C0-BD24-D6B9EA9ED961Q37621354-DE7A09C1-95A8-4176-B764-044FA237C83EQ38167883-D1909354-9ACF-414C-91EE-EF4C35257D28Q38952044-AB0EC188-F1A8-4C8C-9BF9-BB50BD742834Q39032416-B4FA4FC2-9274-4779-9D0C-0AE1B055E664Q39153803-6E925A70-7898-48A5-B0E5-BA0B8C4C8E89Q39276123-21198480-CFDA-4200-9A49-89163ADD7BC5Q40568410-8FD65113-6E46-4201-A96C-6D4D1C668188Q41154638-B947D2CA-80A4-459D-90F4-CD35944FA0F3Q41865636-8BA30EBB-46BF-4617-A4DA-1B6C04458C48Q42396378-D8759010-1333-4025-A8AA-3AA0B6CC9891Q47900854-AE03AE24-1F8A-420D-8A85-ECF9FA698DA3Q49478316-081FD35F-8125-49FD-B47E-76F3FACC6DE0Q50058387-37FEAF44-9C1B-4649-8CB6-13A466A7F3F1Q51072227-1A7D7F24-79AB-4398-8A09-DE97A1D64929Q52742986-F5F7A044-9638-4445-9C10-A92AE5965F78Q53079305-C5C88FA5-FC93-4DA9-8B32-704D94C2D5DCQ55390533-9BAC3686-16D2-4528-A68E-D3D6FD4BB6B9Q55431512-33E26716-FF14-49E6-B8B2-BD02D4666C66Q57022278-5A74E681-A93A-4E6D-9EB9-C1B68010678E
P2860
Cholesterol derivatives based charged liposomes for doxorubicin delivery: preparation, in vitro and in vivo characterization
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Cholesterol derivatives based ...... o and in vivo characterization
@ast
Cholesterol derivatives based ...... o and in vivo characterization
@en
Cholesterol derivatives based ...... o and in vivo characterization
@nl
type
label
Cholesterol derivatives based ...... o and in vivo characterization
@ast
Cholesterol derivatives based ...... o and in vivo characterization
@en
Cholesterol derivatives based ...... o and in vivo characterization
@nl
prefLabel
Cholesterol derivatives based ...... o and in vivo characterization
@ast
Cholesterol derivatives based ...... o and in vivo characterization
@en
Cholesterol derivatives based ...... o and in vivo characterization
@nl
P2093
P2860
P356
P1433
P1476
Cholesterol derivatives based ...... o and in vivo characterization
@en
P2093
Zhongwei Gu
P2860
P304
P356
10.7150/THNO.4949
P577
2012-11-13T00:00:00Z